Forskningsanslag
Föregående års sammanställningar hittar du här.
Barndiabetesfonden forskningsanslag fördelning 2021
Per-Ola Carlsson, Uppsala
Behandla och förhindra typ 1 diabetes med mesenkymala stamceller
2.034.000 kronor
Daniel Espes, Uppsala
Evaluating the effect of GABA on beta-cell regeneration in Type 1 diabetes
1.808.000 kronor
Johnny Ludvigsson, Linköping
Studies of the gut microbiome to decrease the risk of developing Type 1 diabetes.
1.582.000 kronor
Malin Flodström Tullberg, Huddinge
Biomarker(s) for enterovirus-induced beta cell damage
1.582.000 kronor
Johnny Ludvigsson, Linköping
Inovative approaches to preserve residual insulin, especially intralymphatic Autoantigen Therapy in Type 1 diabetes
1.288.000 kronor
Nils Welsh, Uppsala
Adenosine and inosine - two nucleosides so similar in structure but with opposite effects on beta-cell survival in Type 1 diabetes.
1.115.500 kronor
Per Liss, Uppsala
MEDIRF (MR-Evaluation of Diabetes Induced Renal Failure) Studie av njurfunktion hos patienter med diabetesorsakad njurfunktionsnedsättning.
960.500 kronor
Bryndis Birnir, Uppsala
T cell are regulated by GABA, both in health and Type 1 diabetes
904.000 kronor
Olle Korsgren, Uppsala
REsVERaTrol in T1D (REVERT T1D)
847.500 kronor
Joey Lau Börjesson, Uppsala
Will transplanted insulin-producing cells derived from autologous iPSC be tolerated in T1D individuals?
678.000 kronor
Oskar Skog, Uppsala
Elucidating the etiology of Type 1 diabetes with the aim of developing novel intervention strategies
678.000 kronor
Gun Forsander, Göteborg
Azithromycin-Insulin-Diet-intervention-Trial in Type 1 Diabetes (AIDIT)
621.500 kronor
Olof Eriksson, Uppsala
MIDAS study - Macrophage and Neutrophil Imaging in Diabetes
563.914 kronor
Gustaf Christoffersson, Uppsala
A chemokine receptor governing the interplay between islet-resident macrophages and nerves
508.500 kronor
Marcus Lundberg, Uppsala
Undersökning av alfaceller vid typ 1-diabetes
452.000 kronor
Xuan Wang, Uppsala
Origin of extracellular vesicles that participate in the development of Type 1 diabetes: Identity tracking by combined single extracellular vesicle membrane proteomics and islet single cell RNA sequencing
452.000 kronor
Beatrice Kennedy, Uppsala
Cardiovascular Health in Parents to Children with Type 1 diabetes
395.500 kronor
Luis Sarmiento-Pérez, Malmö
Dysregulation of autophagy and extracellular vesicles secretion in pancreatic beta cells-A viral strategy for triggering Type 1 diabetes?
339.000 kronor
(Carina Sparud Lundin, Göteborg
Physical activity in children and young people with Type 1 diabetes – barriers, facilitating factors and support to athletes
297.231 kronor)*
Soffia Guðbjörnsdóttir, Askim
Geographical distribution and influence of environmental factors on the incidence of Type 1 diabetes in Sweden
282.500 kronor
Corrado M Cilio, Malmö
The role of pancreatic tissue immunosurveillance in the development of diabetes
282.500 kronor
Diana Swolin-Eide, Göteborg
En studie av ungdomar med typ 1-diabetes avseende bentäthet och benmarkörer “SweBone Diab”
226.000 kronor
Rosaura Casas, Linköping
Elucidating the mechanism for GAD-alum immunomodulation
226.000 kronor
Isabella Artner, Lund
Neural control of human pancreas development
226.000 kronor
Annelie Carlsson, Lund
The genetic landscape of children with T1D, help in the clinic and in the etiology of the disease
226.000 kronor
Janeth Leksell, Uppsala
Virtuell vård – morgondagen diabetesvård?
226.000 kronor
Brjánn Ljótsson, Solna
Improving self-management in childhood diabetes – the effects of a CBT-based intervention for parents
226.000 kronor
Virginia Stone, Huddinge
Investigating the enterovirus-specific antiviral activity of repurposed drugs in beta-cells and murine models for Type 1 diabetes.
226.000 kronor
Anirudra Parajuli, Huddinge
Exposure to natural materials to prevent Type 1 diabetes
226.000 kronor
Ulf Ahlgren, Umeå
3D reconstruction of the human pancreas with micrometer precision – spatial and quantitative assessment of cellular characteristics of the T1D pancreas
226.000 kronor
Summa: 19.706.145 kronor.
*Fotnot: På grund av omständigheter bortom forskargruppens kontroll blev det nödvändigt att avbryta det föreslagna projektet Physical activity in children and young people with Type 1 diabetes. De anslagna medlen återbetalades i sin helhet till Barndiabetesfonden i januari 2022.